Results 171 to 180 of about 34,166 (308)

Sulphonylurea efficacy and end‐organ outcomes in the management of HNF4A‐MODY

Diabetic Medicine, EarlyView.
Abstract Aims Sulphonylurea agents are typically used to treat HNF4A‐MODY based on the pharmacogenetic aetiology of the condition, although limited evidence exists in the literature for this practice. The aims of this study were to determine the efficacy of sulphonylurea drugs during follow‐up, to explore the role of adjunctive therapies in this cohort
M. T. Crowley, N. Ng, E. Goulden, B. Sanchez‐Lechuga, S. Ludgate, M. Burke, K. Colclough, S. Bacon, M. M. Byrne   +8 more
wiley   +1 more source

Inter-observer agreement of ultrasound shear wave elastography measurements of renal cortical stiffness and morphometry in diabetic patients. [PDF]

Sci Rep
Almutairi FF.
europepmc   +1 more source

Evaluation and surgical management of emergency operation, including that for diabetic nephropathy, in hemodialysis patients.

, 1990
Kouji Soeda, Michio Odaka, Yoichiro Tabata, Kaichi Isono, Toshitsune Shimada, Hiroshi Nishijima, Soichiro Toyoizumi   +6 more
openalex   +2 more sources

Evidence that TGF-β should be a therapeutic target in diabetic nephropathy [PDF]

, 1998
Wayne A. Border, Nancy A. Noble
openalex   +1 more source

Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021

Diabetic Medicine, EarlyView.
Abstract Aims The aim was to evaluate the impact of using an automated insulin delivery (AID) system versus multiple daily insulin injections (MDI) on the odds and costs of acute care utilisation among people with type 1 diabetes (PwT1D). Methods This was retrospective, observational cohort study that leveraged electronic health record (EHR) data and ...
Janna Manjelievskaia, Viral N. Shah, Anders L. Carlson, Diana Isaacs, Sharon M. Wang, Jordan E. Pinsker, Laurel H. Messer, Kimberly W. McDermott, Kevin Lavelle, Stephanie Wall, Diana Brixner, Daniel C. Malone, Charles A. Stemple, Neel Vaidya, Bimal V. Patel   +14 more
wiley   +1 more source

Uticaj metaboličke kontrole na nastanak i razvoj bubrežne lezije u šećernoj bolesti [PDF]

Vojnosanitetski Pregled, 2002
Dragović Tamara
doaj   +1 more source

Eplerenone improves kidney function and cardiac performance in obese male mice

Diabetic Medicine, EarlyView.
Abstract Aims Renin‐angiotensin‐aldosterone system (RAAS) activation mediates obesity‐associated cardiorenal dysfunction. Due to an incomplete understanding of the molecular mechanisms, the clinical use of RAAS antagonism in obesity‐associated cardiometabolic complications remains uncertain.
Ayman K. Banah, Bingxue Qi, Ryan Koh, Alexander Lawlor, Tianzhen Wang, Vishal Musale, Joanne Mains, Colin E. Murdoch, Li Kang   +8 more
wiley   +1 more source

Research on podocyte injury mechanisms in diabetic nephropathy: a bibliometric and knowledge-map analysis from 2000 to 2024. [PDF]

Front Endocrinol (Lausanne)
Lin Y, Tian J.
europepmc   +1 more source

The impact of a family history of Type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with Type I (insulin-dependent) diabetes mellitus [PDF]

, 1999
Johan Fagerudd, Kim Pettersson-Fernholm, Carola Grönhagen‐Riska, Per‐Henrik Groop   +3 more
openalex   +1 more source

Diabetic eye screening in people with diabetes undergoing haemodialysis: A systematic review and meta‐analysis

Diabetic Medicine, EarlyView.
Abstract Aim People with diabetes receiving haemodialysis are at increased risk of diabetic retinopathy (DR) and other ocular complications. Despite this heightened vulnerability, evidence on the prevalence of such conditions in this population is limited.
Hellena Hailu Habte‐Asres, Frehiwot Hailu, Angus Forbes, David C. Wheeler, Tunde Peto   +4 more
wiley   +1 more source